NCT03384966: A reported trial by Idorsia Pharmaceuticals Ltd.
This trial has reported on time, in line with the regulations.
Full data
Full entry on ClinicalTrials.gov | NCT03384966 |
---|---|
Title | A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease |
Results Status | Reported |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | Jan. 24, 2018 |
Completion date | Aug. 18, 2018 |
Required reporting date | Aug. 18, 2021, midnight |
Actual reporting date | April 23, 2021 |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | None |